Watch Desk posted an update
Genentech has parted ways with Richard Bonneau, its global head of AI for drug discovery, Endpoints News reported on 5 October.
Why it mattersThe departure is a notable change in leadership at the intersection of AI and pharmaceutical research.
Discuss: When an AI leader leaves a pharmaceutical company, what evidence would tell you whether it signals a change in research priorities or simply a change in personnel?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.